Company

Neuron23

Biotechnology Research 343 Oyster Point Blvd 38 employees

Employees: 38
Contacts: 4
Emails: 4
Phones: 2

neuron23.com LinkedIn Crunchbase

Neuron23 Overview

Headquarters: 343 Oyster Point Blvd
Website: neuron23.com
Industry: Biotechnology Research
Employees: 38
Founded: 2018
Funding: 96.5M
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

biotech precision medicine immunological diseases neurological diseases neurodegenerative diseases neuroinflammatory diseases autoimmune diseases inflammatory diseases human genetics data science Parkinson's disease Crohn's disease

About Neuron23

Neuron23™ Inc. is a leading clinical-stage biotechnology company focused on developing precision medicines for genetically defined neurological and immunological diseases. Neuron23 combines recent advances in human genetics with a state-of-the-art drug discovery and biomarker platform using advanced techniques in machine learning and artificial intelligence to advance therapeutics for devastating diseases. The Company’s focus areas are neurodegenerative diseases, neuroinflammatory diseases, and systemic autoimmune and inflammatory diseases. Founded in 2018, Neuron23 has assembled a world-class team of experts and entrepreneurs located in South San Francisco, CA.

Neuron23 Contact Details

People in AeroLeads: 4
With contact data: 4
Email contacts: 4; 100.0% coverage
Phone contacts: 2; 50.0% coverage

Neuron23 Org Chart

Sample employees and titles

Name	Title	Location	Contact
Thomas Demelfi	Vice President, Regulatory Affairs and Quality at Neuron23	Ventura County, California, United States	Email
Arash Rassoulpour	Chief Operating Officer at Neuron23	San Diego, California, United States	Email Phone
Luc R. Desnoyers	Senior Vice President Translational R & D at Neuron23 Inc. - Diagnostics - Biomarkers - Drug Development - Strategic Leadership - 1669	South San Francisco, California, United States	Email Phone
Suresh Dheerendra		San Francisco Bay Area, United States	Email